During 2018 Q4 the big money sentiment decreased to 0.79. That’s change of 0.59, from 2018Q3’s 1.38. 59 investors sold all, 85 reduced holdings as ICU Medical, Inc. ratio worsened. 79 grew stakes while 35 funds amassed stakes. Funds hold 20.11 million shares thus 36.17% more from 2018Q3’s 14.77 million shares.
World Asset Mngmt holds 914 shs or 0.01% of its capital. Victory Mgmt Inc owns 0.01% invested in ICU Medical, Inc. (NASDAQ:ICUI) for 10,565 shs. New York-based Teton Advsrs Incorporated has invested 0.2% in ICU Medical, Inc. (NASDAQ:ICUI). Moreover, Mutual Of America Cap Limited Liability Com has 0.1% invested in ICU Medical, Inc. (NASDAQ:ICUI). Moreover, Federated Pa has 0% invested in ICU Medical, Inc. (NASDAQ:ICUI). Moreover, Segall Bryant Hamill Ltd Com has 0.4% invested in ICU Medical, Inc. (NASDAQ:ICUI). Hollencrest Management owns 1,125 shs. Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in ICU Medical, Inc. (NASDAQ:ICUI). Virginia Retirement Systems Et Al invested 0.01% of its capital in ICU Medical, Inc. (NASDAQ:ICUI). Martingale Asset Management Ltd Partnership has 116,969 shs for 0.35% of their capital. The New York-based Oppenheimer Asset Mgmt Incorporated has invested 0.04% in ICU Medical, Inc. (NASDAQ:ICUI). California State Teachers Retirement Systems holds 0.01% of its capital in ICU Medical, Inc. (NASDAQ:ICUI) for 24,567 shs. Partner Investment Mngmt L P holds 0.66% or 2,297 shs. Hussman Strategic Advsrs invested in 0.28% or 5,000 shs. Manufacturers Life Insur The reported 0.01% stake.
ICU Medical, Inc. registered $523.49 million net activity with 0 insider buys and 2 selling transactions since November 15, 2018. On Thursday, November 15 Shares for $523.13M were sold by PFIZER INC.
ICU Medical, Inc. (NASDAQ:ICUI)’s earnings report is anticipated on May, 8., according to Zacks. earnings per share of $2.01 is 2.43 % down from 2018’s $2.06 EPS. If the current earnings per share of $2.01 is accurate, ICUI’s profit could hit $41.40M. 12.92 % EPS growth is what analysts predict. $1.78 earnings per share was reported for previous quarter. ICUI is reaching $225.32 during the last trading session, after decreased 3.94%.ICU Medical, Inc. has 523,650 shares volume, 212.29% up from normal. ICUI is uptrending and has moved 5.87% since April 18, 2018. The stock outperformed the S&P 500 by 1.50%.
ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide.The firm is worth $4.64 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein for use in hospitals and ambulatory clinics.169.41 is the P/E ratio. The company's infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.
For more ICU Medical, Inc. (NASDAQ:ICUI) news posted recently go to: Globenewswire.com, Globenewswire.com, Seekingalpha.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “ICU Medical, Inc. Announces Time of Third Quarter 2018 Earnings Conference Call – GlobeNewswire” posted on October 22, 2018, “ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call – GlobeNewswire” on July 17, 2018, “Pfizer sells $523M stake in ICU Medical to C.P. Pharmaceuticals – Seeking Alpha” with a publish date: November 16, 2018, “ICU Medical, Inc. Announces Fourth Quarter 2018 Results – GlobeNewswire” and the last “ICU Medical: Underfollowed Health Care Supplier – Seeking Alpha” with publication date: November 27, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.